Bone Demineralization, Pathologic: Clinical Trials

5 trials for Bone Demineralization, Pathologic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 2 Phase 4, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Terminated 1
Phase 11Completed 1
Phase 31Completed 1

Follow Bone Demineralization, Pathologic: new trials by email Literature Review of Bone Demineralization, Pathologic trials Research Report on Bone Demineralization, Pathologic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Learn More About the Menopausal Hormone Therapies in Korea
Menopausal hormone therapy Intervention Type: Drug - Menopause, Bone Demineralization
CompletedPfizer10362942023-09-122025-04-18
The Kampala Women's Bone Study
FTC/TDF and DMPA, FTC/TDF, DMPA - Bone Demineralization, Hypoestrogenism
Phase 4CompletedUniversity of Washington5002018-05-152024-06-17
Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss
Alendronate, Placebo, calcium carbonate and colecalciferol - Bone Demineralization
Phase 4TerminatedUniversity College Dublin532016-05-012022-05-26
Calcium and High-dose Vitamin D Supplementation on Bone Mineral Density Among HIV-infected Children and Adolescents
High dose vitamin D and calcium, Normal dose vitamin D and calcium - Adverse Bone Health, HIV Infection
Phase 3CompletedChiang Mai University2002015-04-012019-08-08
Evaluation of Vitamin D Status in Children With Acute Burns
Vitamin D2, Vitamin D3 - Burns, Bone Demineralization
Phase 1CompletedShriners Hospitals for Children502003-03-012012-05-09

Narrower conditions

Acquired Immunodeficiency Syndrome (2)  ·  Bone Diseases (1)  ·  Bone Diseases, Metabolic (1)  ·  Burns (1)  ·  Fractures, Bone (1)  ·  HIV Infections (1)  ·  Osteoporosis (1)

Broader conditions

Metabolic Diseases (5)  ·  Musculoskeletal Diseases (5)  ·  Nutritional and Metabolic Diseases (5)  ·  Bone Diseases (4)  ·  Bone Diseases, Metabolic (4)  ·  Blood-Borne Infections (2)  ·  Communicable Diseases (2)  ·  Genital Diseases (2)  ·  Immune System Diseases (2)  ·  Immunologic Deficiency Syndromes (2)  ·  Infections (2)  ·  Lentivirus Infections (2)  ·  RNA Virus Infections (2)  ·  Retroviridae Infections (2)  ·  Sexually Transmitted Diseases (2)

Interventions

Cholecalciferol (2)  ·  Alendronate (1)  ·  Calcium (1)  ·  Calcium Carbonate (1)  ·  Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1)  ·  Ergocalciferols (1)  ·  N,N-dimethyl-4-anisidine (1)  ·  Tenofovir (1)  ·  Vitamin D (1)

Sponsors

Chiang Mai University (1)  ·  Pfizer (1)  ·  Shriners Hospitals for Children (1)  ·  University College Dublin (1)  ·  University of Washington (1)

Countries

Ireland (1)  ·  South Korea (1)  ·  Thailand (1)  ·  Uganda (1)  ·  United States (1)

Top investigators

Michele M Gottschlich, PhD, RD, CNSD (1)  ·  Patrick WG Mallon, MB BCh BAO,PhD,FRCPI (1)  ·  Renee Heffron, PhD, MPH (1)  ·  Tavitiya Sudjaritruk, MD (1)

Results publications

PMID 15175591, PMID 33305842, PMID 34125899, PMID 36892945, PMID 39630076

NIH funding

R01HD089843 (1)